Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Language Processing | 11 | 2022 | 1041 | 1.660 |
Why?
|
| Electronic Health Records | 17 | 2022 | 4467 | 1.220 |
Why?
|
| Data Mining | 5 | 2021 | 537 | 0.740 |
Why?
|
| Semantics | 1 | 2022 | 585 | 0.650 |
Why?
|
| International Classification of Diseases | 6 | 2020 | 866 | 0.540 |
Why?
|
| Vocabulary, Controlled | 1 | 2016 | 170 | 0.500 |
Why?
|
| Arthralgia | 1 | 2018 | 456 | 0.480 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 824 | 0.470 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 494 | 0.460 |
Why?
|
| Algorithms | 14 | 2022 | 13869 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4422 | 0.290 |
Why?
|
| Radiology | 2 | 2016 | 2099 | 0.250 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2428 | 0.230 |
Why?
|
| Phenotype | 7 | 2022 | 16361 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2016 | 3308 | 0.180 |
Why?
|
| Chondrocalcinosis | 1 | 2021 | 79 | 0.180 |
Why?
|
| Pattern Recognition, Automated | 2 | 2016 | 1001 | 0.170 |
Why?
|
| Spondylarthritis | 1 | 2020 | 62 | 0.170 |
Why?
|
| Pulmonary Embolism | 3 | 2016 | 2375 | 0.170 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2020 | 155 | 0.160 |
Why?
|
| Vital Signs | 1 | 2019 | 142 | 0.160 |
Why?
|
| Area Under Curve | 5 | 2021 | 1654 | 0.160 |
Why?
|
| Pulmonary Artery | 2 | 2016 | 1911 | 0.150 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 225 | 0.150 |
Why?
|
| Creatinine | 1 | 2019 | 1918 | 0.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2016 | 1184 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.120 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14714 | 0.110 |
Why?
|
| Aortic Aneurysm | 1 | 2018 | 644 | 0.110 |
Why?
|
| Registries | 2 | 2021 | 8090 | 0.110 |
Why?
|
| Software | 3 | 2016 | 4440 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2015 | 690 | 0.100 |
Why?
|
| Uncertainty | 1 | 2015 | 735 | 0.090 |
Why?
|
| Angiography | 1 | 2015 | 1638 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15518 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1246 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2019 | 5002 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 1534 | 0.070 |
Why?
|
| Prognosis | 4 | 2021 | 29052 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2104 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3079 | 0.070 |
Why?
|
| Humans | 23 | 2022 | 743811 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4152 | 0.070 |
Why?
|
| Observer Variation | 3 | 2016 | 2592 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 3712 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2020 | 3750 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2861 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2016 | 3817 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3106 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2014 | 4576 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3527 | 0.050 |
Why?
|
| Unified Medical Language System | 1 | 2019 | 86 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2018 | 77410 | 0.040 |
Why?
|
| Female | 11 | 2021 | 380020 | 0.040 |
Why?
|
| Current Procedural Terminology | 1 | 2018 | 92 | 0.040 |
Why?
|
| Male | 10 | 2021 | 349776 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 584 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39001 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13112 | 0.040 |
Why?
|
| Resins, Synthetic | 1 | 2015 | 28 | 0.030 |
Why?
|
| Linear Models | 2 | 2018 | 5952 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15067 | 0.030 |
Why?
|
| Middle Aged | 9 | 2021 | 213241 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20121 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7150 | 0.030 |
Why?
|
| Audiovisual Aids | 1 | 2015 | 92 | 0.030 |
Why?
|
| Rheology | 1 | 2015 | 345 | 0.030 |
Why?
|
| Software Validation | 1 | 2014 | 59 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6485 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 213889 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2014 | 101 | 0.030 |
Why?
|
| Iopamidol | 1 | 2014 | 191 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 19894 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15142 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2712 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 163178 | 0.030 |
Why?
|
| Workflow | 1 | 2016 | 847 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 885 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2241 | 0.020 |
Why?
|
| Survivors | 1 | 2021 | 2291 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1678 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3503 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 2715 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8337 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2103 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9310 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10251 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40545 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 2479 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2015 | 1017 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4406 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2015 | 1880 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 2519 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13980 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 57744 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13273 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5078 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9848 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13404 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10380 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5301 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12259 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15211 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29140 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 23327 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40038 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 72252 | 0.010 |
Why?
|
| United States | 1 | 2017 | 69859 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77637 | 0.010 |
Why?
|
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_